Eko Foundation Analysis Software with Transformers (EFAST) vs Study Watch with Irregular Pulse Monitor (Home)

EFAST integrates seamlessly into a clinician's existing auscultation workflow, providing real-time AI analysis and enhanced audio at the point of care. This direct integration streamlines the diagnostic process for healthcare professionals. In contrast, the Study Watch is a patient-worn device for unobtrusive data collection, which serves a different, more passive monitoring purpose.

EFAST offers high sensitivity and specificity for detecting both structural murmurs (93% sensitivity, 91% specificity) and atrial fibrillation (95% sensitivity, 94% specificity), providing real-time, actionable insights during routine exams. While the Study Watch also detects AFib and collects physiological data, EFAST's ability to diagnose two critical cardiac conditions at the point of care gives it a broader immediate clinical utility.

Tool A (EFAST) provides more transparency regarding its pricing model, indicating it is subscription-based with an Eko+ membership and a free trial with stethoscope purchase, and even an approximate daily cost for its hardware. Tool B (Study Watch) offers no publicly available pricing details, stating it's for clinical research and prescription use, making it difficult to assess its value without direct inquiry.

Both tools are FDA-cleared, cloud-based, and claim HIPAA/BAA compliance. However, Tool A explicitly mentions EMR integration for streamlined documentation and has no reported issues regarding HIPAA. Tool B, despite its claims, has a reported lawsuit alleging HIPAA breaches in past operations, which significantly impacts its trustworthiness and readiness for enterprise-level deployment of sensitive health data.

EFAST demonstrates innovation by applying advanced AI (Transformers) to a traditional clinical tool (stethoscope) for real-time, multi-condition cardiac detection (structural murmurs and AFib) during a routine physical exam. This provides immediate, actionable diagnostic support within an established clinical workflow. While the Study Watch offers innovative multi-sensor, unobtrusive data collection, EFAST's direct impact on point-of-care diagnosis for two distinct conditions sets it apart in terms of immediate clinical utility.

Eko Health provides clear and publicly accessible support resources for EFAST, including user manuals, FAQs, and a dedicated help center, catering to clinicians using their devices and software. In contrast, Verily's Study Watch documentation appears less readily available for general end-users, focusing more on regulatory information and support for institutional or research clients, making Eko Health's support more transparent and accessible.